SARS-CoV-2 and pathological matrix remodeling mediators.

Imen GuizaniNesrine FourtiWiem ZidiMoncef FekiMonia Allal-Elasmi

Published in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2021)

Targeting MMPs and their inhibitors could be a probable solution for occurred events since there are many cured patients that remain with severe sequels even after the end of infection.

Keyphrases

sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
coronavirus disease
drug induced